Kristie Zappas

ID Pharmacist in Biotech Industry
Senior Director, Medical Affairs

[Kristie Zappas @kutlitz]

Save Lives from Sepsis: Act Now, Fight Tomorrow!
Help me reach my goal in raising funds for Sepsis Alliance! https://t.co/NwjumJ2S1H

[Surgical Infection Society @SurgInfxSoc]

The SIS Therapeutics and Guidelines Committee has just released the much-anticipated 2024 update to the Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection.

Read it in the Surgical Infections journal 👉 https://t.co/rTdc8KL9q0

[Kristie Zappas @kutlitz]

@pascalisID Clinda = CDI …. Horrible way to start life parenting a new child.

[ASM @ASMicrobiology]

ASM responded to the FDA regarding the guidance on the use of LDTs during a public health emergency. The ability of labs to respond to emerging or ongoing infectious disease issues is essential to improving patient care. Read our comments: https://t.co/aHpDUPyZj4

[IDSA @IDSAInfo]

NEW #IDSAGuidelines on the treatment of antimicrobial resistant gram-negative infections! This fourth updated guidance document focuses on infections caused by:

• Extended-spectrum β-lactamase-producing Enterobacterales
• AmpC β- lactamase-producing Enterobacterales
• carbapenem-resistant Enterobacterales
• Pseudomonas aeruginosa with difficult-to-treat resistance
• carbapenem-resistant Acinetobacter baumannii
• Stenotrophomonas maltophilia

Read: https://t.co/pRj2pVyR6e

[Surgical Infection Society @SurgInfxSoc]

The SIS Therapeutics and Guidelines Committee has just released the much-anticipated 2024 update to the Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection.

Read it in the Surgical Infections journal 👉 https://t.co/rTdc8KL9q0